Affordability and availability of off-patent drugs in the United States—the case for importing from abroad: observational study

This article was originally published at https://www.drugpatentwatch.com/blog/affordability-and-availability-of-off-patent-drugs-in-the-united-states-the-case-for-importing-from-abroad-observational-study/

This article was originally published by Ravi Gupta, Thomas J Bollyky, Matthew Cohen, Joseph S Ross, and Aaron S Kesselheim  in BMJ 2018;360:k831 under a Creative Commons Attribution Non Commercial (CC BY-NC… The post Affordability and availability of off-patent drugs in the United States—the case for importing from abroad: observational study appeared first on DrugPatentWatch.

Comments are closed.

Biotechblog